These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
913 related items for PubMed ID: 18832579
21. Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells. Genna A, Lapetina S, Lukic N, Twafra S, Meirson T, Sharma VP, Condeelis JS, Gil-Henn H. J Cell Biol; 2018 Jan 02; 217(1):375-395. PubMed ID: 29133485 [Abstract] [Full Text] [Related]
23. Compensatory function of Pyk2 protein in the promotion of focal adhesion kinase (FAK)-null mammary cancer stem cell tumorigenicity and metastatic activity. Fan H, Guan JL. J Biol Chem; 2011 May 27; 286(21):18573-82. PubMed ID: 21471206 [Abstract] [Full Text] [Related]
24. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia. Xu CS, Wang ZF, Huang XD, Dai LM, Cao CJ, Li ZQ. J Transl Med; 2015 Mar 20; 13():95. PubMed ID: 25889845 [Abstract] [Full Text] [Related]
28. Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapy. Guessous F, Yang Y, Johnson E, Marcinkiewicz L, Smith M, Zhang Y, Kofman A, Schiff D, Christensen J, Abounader R. Mol Cancer Ther; 2012 Feb 20; 11(2):288-97. PubMed ID: 22188814 [Abstract] [Full Text] [Related]
30. Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. Lightfoot HM, Lark A, Livasy CA, Moore DT, Cowan D, Dressler L, Craven RJ, Cance WG. Breast Cancer Res Treat; 2004 Nov 20; 88(2):109-16. PubMed ID: 15564794 [Abstract] [Full Text] [Related]
32. Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo. Kurio N, Shimo T, Fukazawa T, Takaoka M, Okui T, Hassan NM, Honami T, Hatakeyama S, Ikeda M, Naomoto Y, Sasaki A. Exp Cell Res; 2011 May 01; 317(8):1134-46. PubMed ID: 21338601 [Abstract] [Full Text] [Related]
33. Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response. Lazaro G, Smith C, Goddard L, Jordan N, McClelland R, Barrett-Lee P, Nicholson RI, Hiscox S. Endocr Relat Cancer; 2013 Oct 01; 20(5):691-704. PubMed ID: 23900794 [Abstract] [Full Text] [Related]
34. Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cells. Lee LT, Huang YT, Hwang JJ, Lee AY, Ke FC, Huang CJ, Kandaswami C, Lee PP, Lee MT. Biochem Pharmacol; 2004 Jun 01; 67(11):2103-14. PubMed ID: 15135307 [Abstract] [Full Text] [Related]
37. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. van Nimwegen MJ, Verkoeijen S, van Buren L, Burg D, van de Water B. Cancer Res; 2005 Jun 01; 65(11):4698-706. PubMed ID: 15930288 [Abstract] [Full Text] [Related]
38. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Agochiya M, Brunton VG, Owens DW, Parkinson EK, Paraskeva C, Keith WN, Frame MC. Oncogene; 1999 Oct 07; 18(41):5646-53. PubMed ID: 10523844 [Abstract] [Full Text] [Related]